Organic Cation Transporter 3 (Oct3), a Potential Suppressor for Hepatocellular Carcinoma

authors:

avatar Bita Moudi ORCID 1 , 2 , avatar Zahra Heidari ORCID 1 , 2 , *

Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Gene, Cell and Tissue: Vol.6, issue 1; e91387
published online: March 17, 2019
article type: Editorial
received: March 9, 2019
accepted: March 11, 2019
DOI: https://doi.org/10.5812/gct.91387

how to cite: Moudi B, Heidari Z. Organic Cation Transporter 3 (Oct3), a Potential Suppressor for Hepatocellular Carcinoma. Gene Cell Tissue. 2019;6(1):e91387. https://doi.org/10.5812/gct.91387.

References

  • 1.

    Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian SM, Lankarani KB, Farrokh P, et al. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. Eur J Histochem. 2018;62(1):2859. [PubMed ID: 29569872]. [PubMed Central ID: PMC5806503]. https://doi.org/10.4081/ejh.2018.2859.

  • 2.

    Bachmakov I, Glaeser H, Endress B, Morl F, Konig J, Fromm MF. Interaction of beta-blockers with the renal uptake transporter OCT2. Diabetes Obes Metab. 2009;11(11):1080-3. [PubMed ID: 19740083]. https://doi.org/10.1111/j.1463-1326.2009.01076.x.

  • 3.

    Gasser PJ, Orchinik M, Raju I, Lowry CA. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol. 2009;512(4):529-55. [PubMed ID: 19025979]. https://doi.org/10.1002/cne.21921.

  • 4.

    Heise M, Lautem A, Knapstein J, Schattenberg JM, Hoppe-Lotichius M, Foltys D, et al. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance. BMC Cancer. 2012;12:109. [PubMed ID: 22439694]. [PubMed Central ID: PMC3323414]. https://doi.org/10.1186/1471-2407-12-109.

  • 5.

    Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells. Oncol Lett. 2018;16(4):5243-8. [PubMed ID: 30250594]. [PubMed Central ID: PMC6144932]. https://doi.org/10.3892/ol.2018.9292.

  • 6.

    Staal YC, van Herwijnen MH, van Schooten FJ, van Delft JH. Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies. Carcinogenesis. 2006;27(3):646-55. [PubMed ID: 16269432]. https://doi.org/10.1093/carcin/bgi255.

  • 7.

    Vollmar J, Lautem A, Closs E, Schuppan D, Kim YO, Grimm D, et al. Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis. Oncotarget. 2017;8(70):115667-80. [PubMed ID: 29383190]. [PubMed Central ID: PMC5777802]. https://doi.org/10.18632/oncotarget.23372.